1 © Patrick An Introduction to Medicinal Chemistry 3/e Chapter 9 DRUG DISCOVERY: FINDING A LEAD Part 4: (Lead compounds - Impact of the human genome project)

Slides:



Advertisements
Présentations similaires
A Showcase of Visualization Approaches for Military Decision Makers
Advertisements

What is the time Mr. Wolf? LObjectif At the end of the lesson, you will be able to: 1.Say quarter past and quarter to the hour.
By the end of this lesson, I will be able to: 1.Ask someone what the time is 2.Tell the time, in French, using oclock half past quarter past quarter to.
Bioinformatique et Biologie Structurale 1 – Principes et techniques A/ Linformation structurale B/ Les différentes techniques de détermination de structure.
Futur Antérieur Par Elizabeth Gribbins. Formation Begin using either the future form of the verb être or avoir (helping verb) Then add the past participle.
By the end of this lesson, I will be able to: 1.Ask someone what the time is 2.Tell the time, in French, using Whole hours Half Hours Quarter Hours.
Are you Muslim, and under 40?
Impact du changement climatique sur la mousson d'Afrique de l'Ouest Philippe Quirion CNRS CIRED et LMD.
La formation et l’usage
Student Management Marks Gaston Berger University School Year Project on Mobile Application Development.
Database irregular verbs Français II. database This is a year-long project. Slide 3 gives students a sample of how to set up the database. Excel (or other.
La norme Iso26000 La norme ISO définit comment les organisations peuvent et doivent contribuer au développement durable. Elle est publiée depuis.
What is a compound tense? It is also called “Complex Tense”. It is a tense that requires an “Auxiliary Verb” in addition to the Ending at the end of the.
Directions: 9 slides with daily routine reflexive verbs in the present, near future and past 1 slide with a non reflexive verb 1 slide must entirely be.
French 2 Passé Composé.
23 (c) 2012 Slide 1 Source: MANAGERIS / Ouvrage: “CREDIBILITY", James M. Kouzes, & Bary Z.
Être Expressions Pg 47 in notebook.
Molecular diagnostics Important to determine treatment 1. Microscope slide based methods using kinetoplast DNA probes 2. PCR Based methods.
Your team’s name. Préselection file You have just downloaded the preselection file: it’s the first step for you to win the challenge! In this file, you.
La pyramide je Je déteste Je déteste faire
THE RECENT PAST. Le passé récent.= the recent past. Le passé récent est un temps du passé, son action se passe juste avant le moment où on parle. Le passé.
Click to edit Master title style Click to edit Master subtitle style.
Jeudi 19 Mars 2009 Quelle heure est-il?. By the end of this lesson, I will be able to: 1.Ask someone what the time is 2.Tell the time, in French, using.
Faire + Infinitif I make my friends laugh.
Français 1 Aller and Venir Chapter 5, Etape 2. Aller – To go Je vais Tu vas Il/elle/on va Nous allons Vous allez Ils/elles vont.
Pays Francophone: _____ - add background and photos -Change fonts, colours, fill slides with pictures. -Delete instructions in brackets. -Copy and paste.
110A (c) 2012 Slide 1 Source: MANAGERIS / Ouvrage: “THE CYCLE OF LEADERSHIP », Noel M. Tichy.
French 1 Chapter 2 Grammar 2
Unité 3 Le passé composé avec ÊTRE. Le passé composé The passé composé is a PAST TENSE used to tell what has happened in the past. As its name implies,
Free PPT Backgrounds. Slide Master  Free Powerpoint Templates  Visit to:
Click to edit Master title style Click to edit Master subtitle style.
French 2 Grammar 2 Chapter 5.  All reflexive verbs only use ETRE as a helping verb in the past  Using être means that all verbs MUST agree with the.
PERFORMANCE One important issue in networking is the performance of the network—how good is it? We discuss quality of service, an overall measurement.
Using the Performance – Potential Assessment.
Click to edit Master title style Click to edit Master subtitle style.
Thegutterpress
INSERT THE TITLE OF YOUR PRESENTATION HERE FREE PPT TEMPLATES ALLPPT.com _ Free PowerPoint Templates, Diagrams and Charts Your Text Here!
Atelier du CLARA : Drug Discovery en oncologie
Equipe Chimie Organique et Médicinale (COM)
Poverty/homelessness
Mardi 4 avril Français I Finish listening (6)
Le Passé Composé avec être
Quelle heure est-il?.
Present Perfect Simple X Present Perfect Continuous.
Le Service d’Observation INDAAF
Today in the computer Lab December 11, 2017
Click to edit Master title style Click to edit Master subtitle style.
ALLPPT.com _ Free PowerPoint Templates, Diagrams and Charts INSERT THE TITLE OF YOUR PRESENTATION HERE FREE PPT TEMPLATES.
Wildlife Photographer of the Year 2013.
Short description Use this slide to show a process. Insert a photo and a brief description of the action. Bilan de professionalization,,,
The consequences of the.
Analyse génomique: comme faire des casse-têtes.
Les récepteurs couplés aux protéines G
LESSON OBJECTIVES By the end of this lesson, I will be able to:
Une très vieille cité des années 1950
TU AS QUEL ÂGE? How old are you?.
Understanding Constraints in Primavera P6Primavera P6.
1 Sétif 16/02/2019 Disorder effect on optical properties of chiral structures, single crystal X-ray diffraction and DFT calculations 1 Laboratoire d'Electrochimie.
Synthèse d’un polyester : l’acide polylactique
Atelier IDEeS –Opportunités pour les réseaux d'innovation
The Best 2007 Les meilleurs de 2007.
Presented by : HAMDI Yosra Faculty of science of Bizerte 1 1.
Test de fonctionnement Pour Slide player.
à écrire des équations de réaction !
Everywhere, we are working with bots … Some data on Chatbots...
Mercredi 10 avril Français I
Use inversion to form questions.
LF
Transcription de la présentation:

1 © Patrick An Introduction to Medicinal Chemistry 3/e Chapter 9 DRUG DISCOVERY: FINDING A LEAD Part 4: (Lead compounds - Impact of the human genome project)

1 © Contents Part 4: Lead compounds - Impact of the human genome project 4.5. Lead Compounds - Impact of the human genome project (6 slides) 4.6. Lead Compounds - de novo design (6 slides) 4.7. Design of Lead Compounds using NMR Spectroscopy (11 slides) [24 slides]

1 © The Past Lead Compound TargetsTargets Lead compounds The Future 4.5 Lead Compounds - Impact of the human genome project

1 © 4.5 Lead Compounds - Impact of the human genome project

1 © 4.5 Lead Compounds - Impact of the human genome project

1 © 4.5 Lead Compounds - Impact of the human genome project

1 © 4.5 Lead Compounds - Impact of the human genome project

1 © 4.5 Lead Compounds - Impact of the human genome project

1 © 4.6 Lead Compounds - de novo design

1 © X-RAY CRYSTALLOGRAPHY

1 © 4.6 Lead Compounds - de novo design PROTEIN STRUCTURE

1 © Receptor 4.6 Lead Compounds - de novo design

1 © Scaffold CO 2 - HO IONICBOND H- BON D VDWBOND Scaffold H3NH3N + O CH 3

1 © N HN O S O ONHN N N H2NH2NH2NH2N S O OON THYMIDYLATE KINASE INHIBITOR ANTICANCER AGENT LEAD COMPOUND Optimisation 4.6 Lead Compounds - de novo design

1 © 4.7 Design of Lead Compounds using NMR Spectroscopy NMR SPECTROSCOPY

1 © Binding Site Protein 4.7 Design of Lead Compounds using NMR Spectroscopy

1 © Protein NO OBSERVABLE BIOLOGICAL EFFECT 4.7 Design of Lead Compounds using NMR Spectroscopy

1 © 13 C NMR C C CH CH CH CH 2 CH Design of Lead Compounds using NMR Spectroscopy

1 © CH 2 CH Design of Lead Compounds using NMR Spectroscopy 13 C NMR C C CH CH CH CH 2 CH 3

1 © Protein 4.7 Design of Lead Compounds using NMR Spectroscopy Optimiseepitope

1 © Protein 4.7 Design of Lead Compounds using NMR Spectroscopy OptimiseepitopeOptimiseepitope

1 © Protein 4.7 Design of Lead Compounds using NMR Spectroscopy OptimiseepitopeOptimiseepitope Link

1 © LEAD COMPOUND 4.7 Design of Lead Compounds using NMR Spectroscopy

1 © Me Design of a lead compound as an immunosuppressant 4.7 Design of Lead Compounds using NMR Spectroscopy Epitope A Epitope B

1 © Me Design of a lead compound as an immunosuppressant 4.7 Design of Lead Compounds using NMR Spectroscopy Lead compound

Feed-back: Politique de confidentialité Feed-back
Do Not Sell My Personal Information
Notre projet: SlidePlayer Les conditions d'utilisation

© 2024 SlidePlayer.fr Inc. All rights reserved.